The notices it replaced
- Reissues: PA-18-615 Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)
Replaced by PAR-24-162.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $742,932 in first-year total cost, median $252,000.
Most frequent study sections
- HIV Comorbidities and Clinical Studies Study Section[HCCS]3
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- HENRY M. JACKSON FDN FOR THE ADV MIL/MED1
- UNIVERSITY OF COLORADO DENVER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Effect of Ubiquitin D variants upon APOL1-mediated kidney injury1R21DK138863-01A1 | ROSS, MICHAEL J | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $252,000 | HCCS |
| 2024 | Effect of ILC3 loss on epithelial barrier function during ART Treated HIV infection1R21DK138855-01A1 | NEFF, CHARLES PRESTON | UNIVERSITY OF COLORADO DENVER, CO | $234,000 | HCCS |
| 2022 | Impact of Microbial Dysbiosis on MAIT Cell Tissue Repair Program after Acute HIV Infection1R21DK132985-01 | CORLEY, MICHAEL JAYPAQUIN-PROULX, DOMINIC | HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD | $256,932 | HCCS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.